About Evotec SE

Company Description

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.

Year founded

1993

Served area

Worldwide

Headcount

3,030

Headquarters

Essener Bogen 7, 22419 Hamburg – Germany

Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
14.06.22 Lanthaler, Dr. Werner Board Buy 226,873.95 € 14.06.22
14.06.22 Lanthaler, Dr. Werner Board Buy 228,559.35 € 14.06.22
14.06.22 Wagner, Wolfgang Board Buy 7,750.00 € 14.06.22
25.01.22 Lanthaler, Dr. Werner Board Other 1,516,614.94 € 25.01.22
25.01.22 Lanthaler, Dr. Werner Board Other 1,508,865.02 € 25.01.22
25.01.22 Spillner, Enno Board Other 371,819.61 € 25.01.22
25.01.22 Spillner, Enno Board Other 369,873.29 € 25.01.22
25.01.22 Dohrmann, Dr. Cord Board Other 447,266.40 € 25.01.22
25.01.22 Dohrmann, Dr. Cord Board Other 444,930.81 € 25.01.22
25.01.22 Johnstone, Dr. Craig Board Other 145,514.63 € 25.01.22
25.01.22 Johnstone, Dr. Craig Board Other 145,479.25 € 25.01.22
25.01.22 Polywka, Dr. Mario Supervisory board Other 424,653.60 € 25.01.22
25.01.22 Polywka, Dr. Mario Supervisory board Other 422,459.56 € 25.01.22
04.01.22 Lanthaler, Dr. Werner Board Buy 392,479.78 € 04.01.22
02.09.21 ELF Partners Group AG Close relation Buy 7,846,965.00 € 02.09.21
02.09.21 Matador Partners Group AG Close relation Sell 7,846,965.00 € 02.09.21
01.09.21 Lanthaler, Dr. Werner Board Other 1,492,060.78 € 01.09.21
01.09.21 Spillner, Enno Board Other 372,335.75 € 01.09.21
01.09.21 Spillner, Enno Board Other 365,796.09 € 01.09.21
01.09.21 Johnstone, Dr. Craig Board Other 271,268.34 € 01.09.21
01.09.21 Johnstone, Dr. Craig Board Other 271,225.87 € 01.09.21
01.09.21 Dohrmann, Dr. Cord Board Other 447,881.52 € 01.09.21
01.09.21 Dohrmann, Dr. Cord Board Other 440,025.44 € 01.09.21
01.09.21 Polywka, Dr. Mario Supervisory board Other 865,612.68 € 01.09.21
01.09.21 Lanthaler, Dr. Werner Board Other 1,518,813.92 € 01.09.21
01.09.21 Ceccaldi-Weng, Maximilien Close relation Sell 15,300.00 € 01.09.21
30.08.21 Brandes, Dr. Jürgen Board Buy 29,000.00 € 30.08.21

Shareholder information

Shares outstanding

176,952,653

IPO

Oct. 28, 2009

Designated Sponsor(s)

Oddo BHF Corporates & Markets AG

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.